These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 18303160)

  • 1. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
    Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
    Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravitreal chemotherapy for intraocular lymphoma].
    Helbig H; Cerny T; de Smet MD
    Ophthalmologe; 2003 Feb; 100(2):145-9. PubMed ID: 12589460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.
    Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS
    Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.
    Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL
    Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proposed protocol of intravitreal injection of methotrexate for treatment of primary vitreoretinal lymphoma.
    Zhou N; Xu X; Liu Y; Wang Y; Wei W
    Eye (Lond); 2022 Jul; 36(7):1448-1455. PubMed ID: 34211136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-10 and interleukin-6 in aqueous humor during treatment of vitreoretinal lymphoma with intravitreally injected methotrexate.
    Kawamura H; Yasuda N; Kakinoki M; Sawada T; Sawada O; Ohji M
    Ophthalmic Res; 2009; 42(3):172-4. PubMed ID: 19648778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of intraocular methotrexate in silicone-filled eyes.
    Hardwig PW; Pulido JS; Bakri SJ
    Retina; 2008 Oct; 28(8):1082-6. PubMed ID: 18779714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose methotrexate for intraocular lymphoma.
    Batchelor TT; Kolak G; Ciordia R; Foster CS; Henson JW
    Clin Cancer Res; 2003 Feb; 9(2):711-5. PubMed ID: 12576439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Asian patient with intraocular lymphoma treated by intravitreal methotrexate.
    Wang JK; Yang CM; Lin CP; Shan YD; Lo AY; Tien HF
    Jpn J Ophthalmol; 2006; 50(5):474-478. PubMed ID: 17013703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
    Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
    JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary intraocular lymphoma invaded to the central nervous system after successful treatment with intraocular methotrexate injection].
    Watanabe K; Arai A; Takase H; Takahashi H; Iwanaga Y; Sugamoto Y; Sugita S; Mochizuki M; Miura O
    Rinsho Ketsueki; 2009 Mar; 50(3):182-6. PubMed ID: 19352085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients.
    Zhou X; Zhou X; Shi H; Lai J; Wang Q; Li Y; Chen K; Li Q; Zhou Q; Cao X; Chen B; Xiao J
    BMC Ophthalmol; 2020 May; 20(1):189. PubMed ID: 32397978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement.
    Smith JR; Rosenbaum JT; Wilson DJ; Doolittle ND; Siegal T; Neuwelt EA; Pe'er J
    Ophthalmology; 2002 Sep; 109(9):1709-16. PubMed ID: 12208721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma.
    Mason JO; Fischer DH
    Ophthalmology; 2003 Jun; 110(6):1241-4. PubMed ID: 12799254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma.
    Velez G; Boldt HC; Whitcup SM; Nussenblatt RB; Robinson MR
    Ophthalmic Surg Lasers; 2002; 33(4):329-33. PubMed ID: 12134997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular methotrexate in ocular diseases other than primary central nervous system lymphoma.
    Hardwig PW; Pulido JS; Erie JC; Baratz KH; Buettner H
    Am J Ophthalmol; 2006 Nov; 142(5):883-5. PubMed ID: 17056381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular T-cell lymphoma due to mycosis fungoides and response to intravitreal methotrexate.
    Reddy R; Kim SJ
    Ocul Immunol Inflamm; 2011 Aug; 19(4):234-6. PubMed ID: 21770799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal methotrexate injections for intraocular involvement in primary central nervous system lymphoma.
    Tourville E; Tardif Y
    Can J Ophthalmol; 2003 Dec; 38(7):598-601. PubMed ID: 14740803
    [No Abstract]   [Full Text] [Related]  

  • 19. Methotrexate treatment for sarcoid-associated panuveitis.
    Dev S; McCallum RM; Jaffe GJ
    Ophthalmology; 1999 Jan; 106(1):111-8. PubMed ID: 9917790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic ocular hypotony with intraocular application of sodium hyaluronate.
    Küçükerdönmez C; Beutel J; Bartz-Schmidt KU; Gelisken F
    Br J Ophthalmol; 2009 Feb; 93(2):235-9. PubMed ID: 18829633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.